Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01591109 | A Reversal in the Vascularity of Metastatic Liver Tumors From Colorectal Cancer After the Cessation of Anti-VEGF Therapy | completed | — | 20 | NHO - Matsumoto Medical CenterOTHER_GOV | 0 | May 3, 2012 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 |
| clinicaltrials |
| NCT00286130 | Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 150 | Central European Cooperative Oncology GroupOTHER | 13 | May 1, 2012 | clinicaltrials |
| NCT01129700 | Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer | completed | Phase 2 | 73 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 27, 2012 | clinicaltrials |
| NCT01370928 | Colonoscopy Screening Using a Novel Slim Colonoscope - a Randomized Controlled Trial | completed | Phase 3 | 190 | Sorlandet Hospital HFOTHER_GOV | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00824161 | Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer | terminated | Phase 2 | 28 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 23, 2012 | clinicaltrials |
| NCT01109615 | Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations(PG) | terminated | Phase 2 | 40 | Vejle HospitalOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT01579591 | VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer | unknown | Phase 3 | 160 | Catholic University of the Sacred HeartOTHER | 1 | Apr 18, 2012 | clinicaltrials |
| NCT01196000 | Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 0 | Apr 17, 2012 | clinicaltrials |
| NCT01574027 | Efficacy of Vitamin D in Colorectal Cancer Chemoprevention | completed | Phase 2 | 55 | University of Illinois at ChicagoOTHER | 1 | Apr 10, 2012 | clinicaltrials |
| NCT01214031 | Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy | unknown | N/A | 70 | Midwest Biomedical ResearchOTHER | 1 | Apr 9, 2012 | clinicaltrials |
| NCT01570452 | Matrilysin Expression in Different Stages of Colorectal Tumors(MMP7) | completed | — | 38 | University of Roma La SapienzaOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT00499395 | Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer | completed | N/A | 4 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00473980 | Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients | completed | Phase 4 | 28 | Göteborg UniversityOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT01566942 | FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer | unknown | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT01552967 | Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma(mXELOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01025960 | A Comparison of Methods to Detect Polyps During Colonoscopy | completed | N/A | 768 | The Cleveland ClinicOTHER | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00689702 | Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer(XERT) | unknown | Phase 2 | 43 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00842686 | Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study(CRAB) | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01152164 | Quality of Life in Patients After Combined Modality Treatment of Rectal Cancer | unknown | — | 167 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00019786 | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases | completed | Phase 2 | 67 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00503932 | Proton Therapy With Capecitabine for Rectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT01126450 | Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT01387880 | Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer(ICE) | completed | Phase 2 | 100 | Herlev HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00137683 | Colorectal Cancer Control in Appalachian Churches | withdrawn | Phase 2 / Phase 3 | 0 | Centers for Disease Control and PreventionFED | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01064999 | A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | unknown | Phase 2 / Phase 3 | 240 | Fudan UniversityOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01549067 | The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey(Sprit) | unknown | — | 3,700 | Chinese Medical Doctor AssociationOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00054977 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | completed | Phase 1 | 40 | Galectin Therapeutics Inc.INDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00003254 | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | completed | Phase 2 | 75 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00020501 | Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | completed | Phase 3 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT01373021 | The Effect of Dexmedetomidine on Postoperative Analgesia | completed | Phase 4 | 95 | Seoul National University HospitalOTHER | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | terminated | Phase 2 | 20 | Galectin Therapeutics Inc.INDUSTRY | 2 | Mar 6, 2012 | clinicaltrials |
| NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma(GFL) | completed | Phase 2 | 48 | Accelerated Community Oncology Research NetworkOTHER | 1 | Mar 1, 2012 | clinicaltrials |
| NCT00532987 | Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer | terminated | — | 22 | Stanford UniversityOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01096381 | Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor | terminated | — | 8 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT00137878 | TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer | completed | Phase 2 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00932308 | Colorectal Inflammatory Response to a Western-Style Diet | completed | N/A | 5 | Rockefeller UniversityOTHER | 1 | Feb 17, 2012 | clinicaltrials |
| NCT00912327 | Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer | completed | — | 18 | HiberCell, Inc.INDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | completed | Phase 1 | 11 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | completed | Phase 2 | 24 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00900094 | UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer(IRB 2000-294) | completed | — | 200 | University of Michigan Rogel Cancer CenterOTHER | 0 | Feb 7, 2012 | clinicaltrials |
| NCT00973557 | The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function | completed | — | 6 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01222208 | Oral Versus Parenteral Nutrition Support to Improve Protein Balance in Colorectal Surgical Patients | completed | N/A | 20 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01527409 | The Efficacy of Health Partnership Program for Cancer Patients | unknown | N/A | 248 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00609310 | Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence | suspended | Phase 2 | 382 | Technische Universität DresdenOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00777478 | Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer(sutent-capiri) | unknown | Phase 1 | 32 | Radboud University Medical CenterOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT01526239 | Reminding Patients of the Important of Colorectal Cancer Screening Results in Patient-Initiated Promoting Colorectal Cancer Screening Via Colonoscopy | completed | N/A | 274 | University of OklahomaOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00208546 | Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer | completed | Phase 3 | 750 | Dutch Colorectal Cancer GroupOTHER | 1 | Feb 2, 2012 | clinicaltrials |
Data updated 23 days agoSource updated May 3, 2012source: clinicaltrials